ZNTL
Zentalis Pharmaceuticals, Inc. · Healthcare
Director Cam Gallagher sold $519K of Zentalis Pharmaceuticals, Inc.
Sold$519,323
$51.93Price
10,000Shares
−2%Stake
What ZNTL did after the filing
- The stock from Wed, Jan 6 close, $48.71
- −21.3%
- S&P 500, same days
- +4.4%
Measured over 30 trading days, to the Feb 19 close.
Traded Mon, Jan 4. Filed Wed, Jan 6, 3:25 PM ET, during the session. Returns use the Jan 6 close and the Feb 19 close. Not investment advice.